Global Initiative for Asthma Updates for Diagnosing Asthma in Adults - Scorecard - MDSpire

Global Initiative for Asthma Updates for Diagnosing Asthma in Adults

  • By

  • Andrew J. Simpson

  • Laura Healy

  • Ran Wang

  • Miriam Bennett

  • Sarah Drake

  • Hannah Wardman

  • Stephen J. Fowler

  • Clare S. Murray

  • Angela Simpson

  • May 22, 2026

  • 0 min

Share

Clinical Scorecard: Revisions to the Global Initiative for Asthma's Diagnostic Criteria for Adult Asthma

At a Glance

CategoryDetail
Condition
Key MechanismsRemoval of airflow limitation (AFL) as a diagnostic criterion and incorporation of type 2 inflammatory biomarkers, which may affect specificity.
Target Population
Care Setting

Key Highlights

  • Verify and clarify the statistics regarding specificity and sensitivity changes.

Guideline-Based Recommendations

Diagnosis

  • Use fractional exhaled nitric oxide and blood eosinophil counts as biomarkers; these tests are critical for identifying type 2 inflammation.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Fluticasone propionate, 250 μg twice a day, is used for treatment response assessment; detail the assessment process.

        Clinical Best Practices

        • Consider type 2 inflammatory biomarkers early in the diagnostic pathway; ensure comprehensive assessment to confirm asthma diagnosis and mitigate overdiagnosis risks.

        Related Resources & Content

        Original Source(s)

        Related Content